PubMed

CGM-A Technology in Evolution.

Skyler JS.

Diabetes Technol Ther. 2009 Feb;11(2):63-4. No abstract available. PMID: 19848571 [PubMed - in process]Related articles

Challenges in developing endpoints for type 1 diabetes intervention studies.

Cernea S, Raz I, Herold KC, Hirshberg B, Roep BO, Schatz DA, Fleming GA, Pozzilli P, Little R, Schloot NC, Leslie RD, Skyler JS, Palmer JP.

Diabetes Metab Res Rev. 2009 Nov;25(8):694-704.PMID: 19771545 [PubMed - in process]Related articles

Pancreatic Islet Autoantibodies as Predictors of Type 1 Diabetes in the Diabetes Prevention Trial-Type 1 (DPT-1).

Orban T, Sosenko JM, Cuthbertson D, Krischer JP, Skyler JS, Jackson R, Yu L, Palmer JP, Schatz D, Eisenbarth G; Diabetes Prevention Trial-1Study Group.

Diabetes Care. 2009 Sep 9. [Epub ahead of print]PMID: 19741189 [PubMed - as supplied by publisher]Related articles

Central obesity and insulin resistance in the cardiometabolic syndrome: pathways to preclinical cardiovascular structure and function.

Klaus JR, Hurwitz BE, Llabre MM, Skyler JS, Goldberg RB, Marks JB, Bilsker MS, Schneiderman N.

J Cardiometab Syndr. 2009 Spring;4(2):63-71.PMID: 19614791 [PubMed - indexed for MEDLINE]Related articles

Continuous glucose monitoring: an overview of its development.

Skyler JS.

Diabetes Technol Ther. 2009 Jun;11 Suppl 1:S5-10. Review. No abstract available. PMID: 19469678 [PubMed - indexed for MEDLINE]Related articles

Insulin glargine and cancer--an unsubstantiated allegation.

Garg SK, Hirsch IB, Skyler JS.

Diabetes Technol Ther. 2009 Aug;11(8):473-6. No abstract available. PMID: 19591544 [PubMed - in process]Related articles

Incident dysglycemia and progression to type 1 diabetes among participants in the Diabetes Prevention Trial-Type 1.

Sosenko JM, Palmer JP, Rafkin-Mervis L, Krischer JP, Cuthbertson D, Mahon J, Greenbaum CJ, Cowie CC, Skyler JS; Diabetes Prevention Trial-Type 1 Study Group.

Diabetes Care. 2009 Sep;32(9):1603-7. Epub 2009 Jun 1.PMID: 19487644 [PubMed - indexed for MEDLINE]Related articles

High-dose insulin therapy: is it time for U-500 insulin?

Lane WS, Cochran EK, Jackson JA, Scism-Bacon JL, Corey IB, Hirsch IB, Skyler JS.

Endocr Pract. 2009 Jan-Feb;15(1):71-9. Review.PMID: 19211405 [PubMed - indexed for MEDLINE]Related articles

Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association.

Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS; American Diabetes Association; American College of Cardiology Foundation; American Heart Association.

J Am Coll Cardiol. 2009 Jan 20;53(3):298-304. Review. No abstract available. PMID: 19147051 [PubMed - indexed for MEDLINE]Related articles

Update on worldwide efforts to prevent type 1 diabetes.

Skyler JS; Type 1 Diabetes TrialNet Study Group.

Ann N Y Acad Sci. 2008 Dec;1150:190-6. Review.PMID: 19120293 [PubMed - indexed for MEDLINE]Related articles

Type 1 Diabetes TrialNet--an international collaborative clinical trials network.

Skyler JS, Greenbaum CJ, Lachin JM, Leschek E, Rafkin-Mervis L, Savage P, Spain L; Type 1 Diabetes TrialNet Study Group.

Ann N Y Acad Sci. 2008 Dec;1150:14-24.PMID: 19120262 [PubMed - indexed for MEDLINE]Related articles

Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association.

Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS; American Diabetes Association; American College of Cardiology Foundation; American Heart Association.

Circulation. 2009 Jan 20;119(2):351-7. Epub 2008 Dec 17. Review. No abstract available. Erratum in: Circulation. 2009 Jun 30;119(25):e605. PMID: 19095622 [PubMed - indexed for MEDLINE]Related articles

Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association.

Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS; American Diabetes Association; American College of Cardiology Foundation; American Heart Association.

Diabetes Care. 2009 Jan;32(1):187-92. Epub 2008 Dec 17. No abstract available. PMID: 19092168 [PubMed - in process]Related articlesFree article

Safety and efficacy of inhaled human insulin (Exubera) during discontinuation and readministration of therapy in adults with type 1 diabetes: A 3-year randomized controlled trial.

Skyler JS, Hollander PA, Jovanovic L, Klioze S, Krasner A, Riese RJ, Reis J, Schwartz P, Duggan W; Inhaled Human Insulin Type 1 Diabetes Study Group.

Diabetes Res Clin Pract. 2008 Nov;82(2):238-46. Epub 2008 Sep 27.PMID: 18824271 [PubMed - indexed for MEDLINE]Related articles

The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results.

Mahon JL, Sosenko JM, Rafkin-Mervis L, Krause-Steinrauf H, Lachin JM, Thompson C, Bingley PJ, Bonifacio E, Palmer JP, Eisenbarth GS, Wolfsdorf J, Skyler JS; TrialNet Natural History Committee; Type 1 Diabetes TrialNet Study Group.

Pediatr Diabetes. 2009 Apr;10(2):97-104. Epub 2008 Sep 24.PMID: 18823409 [PubMed - indexed for MEDLINE]Related articles

Latent autoimmune diabetes in adults: the search for interventions continues.

Skyler JS.

Nat Clin Pract Endocrinol Metab. 2008 Nov;4(11):600-1. Epub 2008 Sep 2. No abstract available. PMID: 18762790 [PubMed]Related articles

Glucose and C-peptide changes in the perionset period of type 1 diabetes in the Diabetes Prevention Trial-Type 1.

Sosenko JM, Palmer JP, Rafkin-Mervis L, Krischer JP, Cuthbertson D, Matheson D, Skyler JS.

Diabetes Care. 2008 Nov;31(11):2188-92. Epub 2008 Jul 23.PMID: 18650369 [PubMed - indexed for MEDLINE]Related articlesFree article

Prevention of type 1 diabetes: the time has come.

Sherr J, Sosenko J, Skyler JS, Herold KC.

Nat Clin Pract Endocrinol Metab. 2008 Jun;4(6):334-43. Epub 2008 Apr 29. Review.PMID: 18446141 [PubMed - indexed for MEDLINE]Related articles

Unexplained hyperglycemia in continuous subcutaneous insulin infusion: evaluation and treatment.

Ponder SW, Skyler JS, Kruger DF, Matheson D, Brown BW.

Diabetes Educ. 2008 Mar-Apr;34(2):327-33.PMID: 18375782 [PubMed - indexed for MEDLINE]Related articles

Thirty years of diabetes care: reflections on the beginning.

Skyler JS.

Diabetes Care. 2008 Jan;31(1):183-4. No abstract available. PMID: 18165350 [PubMed - indexed for MEDLINE]Related articlesFree article

A risk score for type 1 diabetes derived from autoantibody-positive participants in the diabetes prevention trial-type 1.

Sosenko JM, Krischer JP, Palmer JP, Mahon J, Cowie C, Greenbaum CJ, Cuthbertson D, Lachin JM, Skyler JS; Diabetes Prevention Trial-Type 1 Study Group.

Diabetes Care. 2008 Mar;31(3):528-33. Epub 2007 Nov 13.PMID: 18000175 [PubMed - indexed for MEDLINE]Related articlesFree article

Pulmonary insulin delivery--state of the art 2007.

Skyler JS.

Diabetes Technol Ther. 2007 Jun;9 Suppl 1:S1-3. Review. No abstract available. PMID: 17563297 [PubMed - indexed for MEDLINE]Related articles

Cellular therapy for type 1 diabetes: has the time come?

Skyler JS.

JAMA. 2007 Apr 11;297(14):1599-600. No abstract available. PMID: 17426281 [PubMed - indexed for MEDLINE]Related articles

Prediction and prevention of type 1 diabetes: progress, problems, and prospects.

Skyler JS.

Clin Pharmacol Ther. 2007 May;81(5):768-71. Epub 2007 Mar 28. Review.PMID: 17392722 [PubMed - indexed for MEDLINE]Related articles

Two-year safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 1 diabetes.

Skyler JS, Jovanovic L, Klioze S, Reis J, Duggan W; Inhaled Human Insulin Type 1 Diabetes Study Group.

Diabetes Care. 2007 Mar;30(3):579-85.PMID: 17327324 [PubMed - indexed for MEDLINE]Related articlesFree article

Suppression of human immunodeficiency virus type 1 viral load with selenium supplementation: a randomized controlled trial.

Hurwitz BE, Klaus JR, Llabre MM, Gonzalez A, Lawrence PJ, Maher KJ, Greeson JM, Baum MK, Shor-Posner G, Skyler JS, Schneiderman N.

Arch Intern Med. 2007 Jan 22;167(2):148-54.PMID: 17242315 [PubMed - indexed for MEDLINE]Related articlesFree article

Increasing the accuracy of oral glucose tolerance testing and extending its application to individuals with normal glucose tolerance for the prediction of type 1 diabetes: the Diabetes Prevention Trial-Type 1.

Sosenko JM, Palmer JP, Greenbaum CJ, Mahon J, Cowie C, Krischer JP, Chase HP, White NH, Buckingham B, Herold KC, Cuthbertson D, Skyler JS; Diabetes Prevention Trial-Type 1 Study Group.

Diabetes Care. 2007 Jan;30(1):38-42.PMID: 17192330 [PubMed - indexed for MEDLINE]Related articlesFree article

Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1.

Sosenko JM, Palmer JP, Greenbaum CJ, Mahon J, Cowie C, Krischer JP, Chase HP, White NH, Buckingham B, Herold KC, Cuthbertson D, Skyler JS.

Diabetes Care. 2006 Mar;29(3):643-9.PMID: 16505520 [PubMed - indexed for MEDLINE]Related articlesFree article

Aberrant parasympathetic and hemodynamic function distinguishes a subgroup of psychologically distressed individuals with asymptomatic type-I diabetes mellitus.

Motivala SJ, Hurwitz BE, LaGreca AM, Llabre MM, Marks JB, Skyler JS, Schneiderman N.

Int J Behav Med. 1999;6(1):78-94.PMID: 16250693 [PubMed]Related articles

Pulmonary insulin update.

Skyler JS.

Diabetes Technol Ther. 2005 Oct;7(5):834-9. Review. No abstract available. PMID: 16241894 [PubMed - indexed for MEDLINE]Related articles

Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects: a 6-month, randomized, comparative trial.

Skyler JS, Weinstock RS, Raskin P, Yale JF, Barrett E, Gerich JE, Gerstein HC; Inhaled Insulin Phase III Type 1 Diabetes Study Group.

Diabetes Care. 2005 Jul;28(7):1630-5.PMID: 15983312 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1.

Skyler JS, Krischer JP, Wolfsdorf J, Cowie C, Palmer JP, Greenbaum C, Cuthbertson D, Rafkin-Mervis LE, Chase HP, Leschek E.

Diabetes Care. 2005 May;28(5):1068-76.PMID: 15855569 [PubMed - indexed for MEDLINE]Related articlesFree article

HIV, metabolic syndrome X, inflammation, oxidative stress, and coronary heart disease risk : role of protease inhibitor exposure.

Hurwitz BE, Klimas NG, Llabre MM, Maher KJ, Skyler JS, Bilsker MS, McPherson-Baker S, Lawrence PJ, Laperriere AR, Greeson JM, Klaus JR, Lawrence R, Schneiderman N.

Cardiovasc Toxicol. 2004;4(3):303-16.PMID: 15470277 [PubMed - indexed for MEDLINE]Related articles

Diabetes mellitus: pathogenesis and treatment strategies.

Skyler JS.

J Med Chem. 2004 Aug 12;47(17):4113-7. Review.PMID: 15293979 [PubMed - indexed for MEDLINE]Related articles

C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001.

Palmer JP, Fleming GA, Greenbaum CJ, Herold KC, Jansa LD, Kolb H, Lachin JM, Polonsky KS, Pozzilli P, Skyler JS, Steffes MW.

Diabetes. 2004 Jan;53(1):250-64. Erratum in: Diabetes. 2004 Jul;53(7):1934. PMID: 14693724 [PubMed - indexed for MEDLINE]Related articlesFree article

Diabetes trends in the USA.

Skyler JS, Oddo C.

Diabetes Metab Res Rev. 2002 Sep-Oct;18 Suppl 3:S21-6. Review.PMID: 12324981 [PubMed - indexed for MEDLINE]Related articles

Microvascular complications. Retinopathy and nephropathy.

Skyler JS.

Endocrinol Metab Clin North Am. 2001 Dec;30(4):833-56. Review.PMID: 11727402 [PubMed - indexed for MEDLINE]Related articles

Modeling preclinical cardiovascular risk for use in epidemiologic studies: Miami community health study.

Goldstein RZ, Hurwitz BE, Llabre MM, Schneiderman N, Gutt M, Skyler JS, Prineas RJ, Donahue RP.

Am J Epidemiol. 2001 Oct 15;154(8):765-76.PMID: 11590090 [PubMed - indexed for MEDLINE]Related articlesFree article

The economic burden of diabetes and the benefits of improved glycemic control: the potential role of a continuous glucose monitoring system.

Skyler JS.

Diabetes Technol Ther. 2000;2 Suppl 1:S7-12. Review. No abstract available. PMID: 11469636 [PubMed - indexed for MEDLINE]Related articles

Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study.

Skyler JS, Cefalu WT, Kourides IA, Landschulz WH, Balagtas CC, Cheng SL, Gelfand RA.

Lancet. 2001 Feb 3;357(9253):331-5.PMID: 11210993 [PubMed - indexed for MEDLINE]Related articles

Inhaled human insulin treatment in patients with type 2 diabetes mellitus.

Cefalu WT, Skyler JS, Kourides IA, Landschulz WH, Balagtas CC, Cheng S, Gelfand RA; Inhaled Insulin Study Group.

Ann Intern Med. 2001 Feb 6;134(3):203-7.PMID: 11177333 [PubMed - indexed for MEDLINE]Related articlesFree article

Validation of the insulin sensitivity index (ISI(0,120)): comparison with other measures.

Gutt M, Davis CL, Spitzer SB, Llabre MM, Kumar M, Czarnecki EM, Schneiderman N, Skyler JS, Marks JB.

Diabetes Res Clin Pract. 2000 Mar;47(3):177-84.PMID: 10741566 [PubMed - indexed for MEDLINE]Related articles

Therapeutic controversy: prevention and treatment of diabetes in children.

Rosenbloom AL, Schatz DA, Krischer JP, Skyler JS, Becker DJ, Laporte RE, Libman I, Pietropaolo M, Dosch HM, Finberg L, Muir A, Tamborlane WV, Grey M, Silverstein JH, Malone JI.

J Clin Endocrinol Metab. 2000 Feb;85(2):494-522. Review. No abstract available. PMID: 10690847 [PubMed - indexed for MEDLINE]Related articlesFree article

History of gestational diabetes, insulin resistance and coronary risk.

Davis CL, Gutt M, Llabre MM, Marks JB, O'Sullivan MJ, Potter JE, Landel JL, Kumar M, Schneiderman N, Gellman M, Skyler JS.

J Diabetes Complications. 1999 Jul-Aug;13(4):216-23.PMID: 10616862 [PubMed - indexed for MEDLINE]Related articles

New diabetes criteria and clinical implications.

Skyler JS.

Drugs. 1999;58 Suppl 1:1-2; discussion 75-82. No abstract available. PMID: 10576515 [PubMed - indexed for MEDLINE]Related articles

Is fasting leptin associated with insulin resistance among nondiabetic individuals? The Miami Community Health Study.

Donahue RP, Prineas RJ, Donahue RD, Zimmet P, Bean JA, De Courten M, Collier G, Goldberg RB, Skyler JS, Schneiderman N.

Diabetes Care. 1999 Jul;22(7):1092-6.PMID: 10388973 [PubMed - indexed for MEDLINE]Related articlesFree article

Simplifying the diagnosis of diabetes mellitus.

Skyler JS.

Am Fam Physician. 1998 Oct 15;58(6):1290-2. No abstract available. PMID: 9803187 [PubMed - indexed for MEDLINE]Related articles

Targeted glycemic control in type 2 diabetes.

Skyler JS.

J Fla Med Assoc. 1998 Aug;85(2):7-15. No abstract available. PMID: 9782713 [PubMed - indexed for MEDLINE]Related articles

Prevention of type 1 diabetes.

Rabinovitch A, Skyler JS.

Med Clin North Am. 1998 Jul;82(4):739-55. Review.PMID: 9706119 [PubMed - indexed for MEDLINE]Related articles

The relation of fasting insulin to blood pressure in a multiethnic population: the Miami Community Health Study.

Donahue RP, Prineas RJ, Bean JA, deCarlo Donahue RA, Goldberg RB, Skyler JS, Schneiderman N.

Ann Epidemiol. 1998 May;8(4):236-44.PMID: 9590602 [PubMed - indexed for MEDLINE]Related articles